FDA Approves New Gilead Hepatitis C Combination Drug
The U.S. Food and Drug Administration on Friday approved the first combination drug to treat a common form of the hepatitis C virus on its own, giving the green light to...To view the full article, register now.
Already a subscriber? Click here to view full article